99 related articles for article (PubMed ID: 15502222)
1. Simultaneous quantification of t(14;18) and HPRT exon 2/3 deletions in human lymphocytes.
Fuscoe JC
Methods Mol Biol; 2005; 291():171-8. PubMed ID: 15502222
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous quantification of t(14;18) and HPRT exon 2/3 deletions in human lymphocytes.
Fuscoe JC
Methods Mol Biol; 2014; 1105():303-11. PubMed ID: 24623238
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous Quantification of t(14;18) and HPRT Exon 2/3 Deletions in Human Lymphocytes.
Fuscoe JC
Methods Mol Biol; 2020; 2102():361-370. PubMed ID: 31989567
[TBL] [Abstract][Full Text] [Related]
4. Quantification of illegitimate V(D)J recombinase-mediated mutations in lymphocytes of newborns and adults.
Scheerer JB; Xi L; Knapp GW; Setzer RW; Bigbee WL; Fuscoe JC
Mutat Res; 1999 Dec; 431(2):291-303. PubMed ID: 10635995
[TBL] [Abstract][Full Text] [Related]
5. The frequency of illegitimate TCRbeta/gamma gene recombination in human lymphocytes: influence of age, environmental exposure and cytostatic treatment, and correlation with frequencies of t(14;18) and hprt mutation.
Meydan D; Nilsson T; Törnblom M; Hagmar L; Hellgren D; Fuscoe JC; Lambert B
Mutat Res; 1999 Aug; 444(2):393-403. PubMed ID: 10521679
[TBL] [Abstract][Full Text] [Related]
6. Quantification of hprt gene deletions mediated by illegitimate V(D)J recombination in peripheral blood cells of humans.
Fuscoe JC; Vira LK; Collard DD; Moore MM
Environ Mol Mutagen; 1997; 29(1):28-35. PubMed ID: 9020304
[TBL] [Abstract][Full Text] [Related]
7. V(D)J recombinase-mediated HPRT mutations in peripheral blood lymphocytes of normal children.
Finette BA; Poseno T; Albertini RJ
Cancer Res; 1996 Mar; 56(6):1405-12. PubMed ID: 8640832
[TBL] [Abstract][Full Text] [Related]
8. The frequency of illegitimate V(D)J recombinase-mediated mutations in children treated with etoposide-containing antileukemic therapy.
Fuscoe JC; Knapp GW; Hanley NM; Setzer RW; Sandlund JT; Pui CH; Relling MV
Mutat Res; 1998 Nov; 419(1-3):107-21. PubMed ID: 9804912
[TBL] [Abstract][Full Text] [Related]
9. A human lymphoid leukemia cell line with a V(D)J recombinase-mediated deletion of hprt.
Chen CL; Woo MH; Neale GA; Goorha RM; Fuscoe JC; Behm FG; Mathew S; Relling MV
Mutat Res; 1998 Jul; 403(1-2):113-25. PubMed ID: 9726012
[TBL] [Abstract][Full Text] [Related]
10. Alternative end-joining in follicular lymphomas' t(14;18) translocation.
Marculescu R; Le T; Böcskör S; Mitterbauer G; Chott A; Mannhalter C; Jaeger U; Nadel B
Leukemia; 2002 Jan; 16(1):120-6. PubMed ID: 11840271
[TBL] [Abstract][Full Text] [Related]
11. A non-B-DNA structure at the Bcl-2 major breakpoint region is cleaved by the RAG complex.
Raghavan SC; Swanson PC; Wu X; Hsieh CL; Lieber MR
Nature; 2004 Mar; 428(6978):88-93. PubMed ID: 14999286
[TBL] [Abstract][Full Text] [Related]
12. V(D)J recombinase-mediated deletion of the hprt gene in T-lymphocytes from adult humans.
Fuscoe JC; Zimmerman LJ; Harrington-Brock K; Burnette L; Moore MM; Nicklas JA; O'Neill JP; Albertini RJ
Mutat Res; 1992 Sep; 283(1):13-20. PubMed ID: 1380658
[TBL] [Abstract][Full Text] [Related]
13. t(14;18) chromosomal translocation in follicular lymphoma: an event occurring with almost equal frequency both at the D to J(H) and at later stages in the rearrangement process of the immunoglobulin heavy chain gene locus.
Stamatopoulos K; Kosmas C; Belessi C; Papadaki T; Afendaki S; Anagnostou D; Loukopoulos D
Br J Haematol; 1997 Dec; 99(4):866-72. PubMed ID: 9432035
[TBL] [Abstract][Full Text] [Related]
14. Use of inverse PCR to amplify and sequence breakpoints of HPRT deletion and translocation mutations.
Williams M; Rainville IR; Nicklas JA
Environ Mol Mutagen; 2002; 39(1):22-32. PubMed ID: 11813293
[TBL] [Abstract][Full Text] [Related]
15. Variability of quantitative polymerase chain reaction detection of the bcl-2-IgH translocation in an international multicenter study.
Darby AJ; Lanham S; Soubeyran P; Johnson PW
Haematologica; 2005 Dec; 90(12):1706-7. PubMed ID: 16330451
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneous breakpoints on the immunoglobulin genes are involved in fusion with the 5' region of BCL2 in B-cell tumors.
Yonetani N; Ueda C; Akasaka T; Nishikori M; Uchiyama T; Ohno H
Jpn J Cancer Res; 2001 Sep; 92(9):933-40. PubMed ID: 11572760
[TBL] [Abstract][Full Text] [Related]
17. Novel types of mutation identified at the hprt locus of human T-lymphocytes.
Hou SM
Mutat Res; 1994 Jul; 308(1):23-31. PubMed ID: 7516483
[TBL] [Abstract][Full Text] [Related]
18. Quantification of t(14;18) in the lymphocytes of healthy adult humans as a possible biomarker for environmental exposures to carcinogens.
Fuscoe JC; Setzer RW; Collard DD; Moore MM
Carcinogenesis; 1996 May; 17(5):1013-20. PubMed ID: 8640906
[TBL] [Abstract][Full Text] [Related]
19. Illegitimate V(D)J recombination-mediated deletions in Notch1 and Bcl11b are not sufficient for extensive clonal expansion and show minimal age or sex bias in frequency or junctional processing.
Champagne DP; Shockett PE
Mutat Res; 2014 Mar; 761():34-48. PubMed ID: 24530429
[TBL] [Abstract][Full Text] [Related]
20. Lack of evidence for an association between the frequency of mutants or translocations in circulating lymphocytes and exposure to radon gas in the home.
Cole J; Green MH; Bridges BA; Waugh AP; Beare DM; Henshaw D; Last R; Liu Y; Cortopassi G
Radiat Res; 1996 Jan; 145(1):61-9. PubMed ID: 8532838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
